BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7299690)

  • 1. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.
    McManus ME; Monks A; Collins JM; White R; Strong JM
    J Pharmacol Exp Ther; 1981 Dec; 219(3):669-74. PubMed ID: 7299690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
    J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the O-demethylation of misonidazole by rat liver microsomes.
    Shoemaker DD; McManus ME; Hoerauf R; Strong JM
    Cancer Treat Rep; 1982 Jun; 66(6):1343-7. PubMed ID: 7083238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and excretion of [3H]misonidazole by hypoxic rat liver.
    Smith BR; Born JL
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1365-70. PubMed ID: 6469758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
    Dische S; Saunders MI; Riley PJ; Hauck J; Bennett MH; Stratford MR; Minchinton AI
    Br J Cancer; 1981 Mar; 43(3):344-9. PubMed ID: 7225285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cimetidine, antipyrine, and pregnenolone carbonitrile on misonidazole pharmacokinetics.
    Workman P; Donaldson J; Smith NC
    Cancer Treat Rep; 1983; 67(7-8):723-5. PubMed ID: 6871889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological changes in rat hepatocytes in primary culture induced by Misonidazole, desmethylmisonidazole and Ro 03-8799.
    Smith RA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 46(1-2):65-76. PubMed ID: 6147929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-pharmacokinetic relationships for misonidazole analogues in mice.
    Workman P; Brown JM
    Cancer Chemother Pharmacol; 1981; 6(1):39-49. PubMed ID: 7273265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose and flow dependence of 5-fluorouracil elimination by the isolated perfused rat liver.
    Warren BS; LaCreta FP; Kornhauser DM; Williams WM
    Cancer Res; 1987 Oct; 47(20):5261-5. PubMed ID: 3652033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport is not rate-limiting in morphine glucuronidation in the single-pass perfused rat liver preparation.
    Doherty MM; Poon K; Tsang C; Pang KS
    J Pharmacol Exp Ther; 2006 May; 317(2):890-900. PubMed ID: 16464965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
    White RA; Workman P
    Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal elimination of the hypoxic cell radiosensitizer misonidazole in Wistar rats: influence of some drugs on its excretion.
    Akel G; Canal P; Soula G
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):181-7. PubMed ID: 4085520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. II. Kinetics of steady state elimination.
    Saville BA; Gray MR; Tam YK
    Drug Metab Dispos; 1987; 15(1):17-21. PubMed ID: 2881753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
    Horowitz M; Blasberg R; Molnar P; Strong J; Kornblith P; Pleasants R; Fenstermacher J
    Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY; Workman P
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.
    Tanswell P; Heinzel G; Greischel A; Krause J
    J Pharmacol Exp Ther; 1990 Oct; 255(1):318-24. PubMed ID: 2120422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the xanthine oxidase inhibitor allopurinol on the renal clearance of nitroimidazoles.
    Workman P; White RA
    Biochem Pharmacol; 1982 Oct; 31(19):3041-6. PubMed ID: 6897355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver.
    Harris BE; Song RL; Soong SJ; Diasio RB
    Cancer Res; 1989 Dec; 49(23):6610-4. PubMed ID: 2819711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
    Egfjord M
    Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
    Blasberg R; Horowitz M; Strong J; Molnar P; Patlak C; Owens E; Fenstermacher J
    Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.